Sometimes, the best time to invest in a relatively new market is after the initial euphoria has evaporated. That could very well be the case with investing in CBD, an abbreviation for a chemical found in the cannabis plant called cannabidiol. CBD stocks are shares of publicly traded companies that are involved in the processing and distribution of CBD or provide tools and services to other companies in the CBD industry.
The U.S. legalized hemp-derived CBD at the federal level with the 2018 farm bill. The mere anticipation of the passage of this legislation stoked investors' interest in the stocks of companies involved in the CBD industry.
Although federal legalization served as a key milestone, the U.S. Food and Drug Administration (FDA) chose to exclude CBD from food supplements. As a result, the CBD opportunity in the U.S. hasn't delivered on investors' lofty ambitions.
The CBD industry faces another big challenge in 2026. A continuing resolution passed by the U.S. Congress in November 2025 made significant changes to federal hemp product regulations.
Top CDB stocks for 2026
Although the CBD market isn't as attractive as it once was due to the uncertainties created by these changes, investors may still want to consider four CBD stocks:
| Name and ticker | Current price | Market cap |
|---|---|---|
| Cresco Labs (OTC:CRLBF) | $0.98 | $340.1 million |
| Green Thumb Industries (OTC:GTBIF) | $6.56 | $1.5 billion |
| Jazz Pharmaceuticals Plc (NASDAQ:JAZZ) | $178.55 | $11.1 billion |
| Trulieve Cannabis (OTC:TCNNF) | $6.40 | $1.2 billion |
1. Cresco Labs
OTC: CRLBF
Key Data Points
2. Green Thumb Industries
OTC: GTBIF
Key Data Points
NASDAQ: JAZZ
Key Data Points
OTC: TCNNF
Key Data Points
Related investing topics
FAQ
Investing in CBD stocks FAQ
About the Author
